News

What is ALS? Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that attacks nerve cells and pathways in the brain and spinal cord.
Amyotrophic Lateral Sclerosis, later to be known as ‘Lou Gehrig’s Disease’ took the Hall of Fame Yankee first baseman’s life on June 2, 1941, at age 37.
Prescribed use of anxiolytics, hypnotics and sedatives, or antidepressants was associated with a significantly increased risk for future development of amyotrophic lateral sclerosis (ALS) and a ...
The segment, which ABC previewed last week, is Dane’s first major interview about his illness since the Euphoria actor revealed his amyotrophic lateral sclerosis (ALS) diagnosis to People ...
Actor Eric Dane is opening up about living with ALS. In his first television interview since revealing he has amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease, Dane, 52 ...
Eric Dane is slowly losing function in his body amid his “sobering” battle with amyotrophic lateral sclerosis (ALS). The “Grey’s Anatomy” alum discussed his struggles for the first time ...
The tech developed by researchers at University of California, Davis (UC Davis) was trialed with a study participant who suffers from amyotrophic lateral sclerosis (ALS).
Eric Dane’s Health In April 2025, Eric told People about his diagnosis with Amyotrophic lateral sclerosis (ALS). “I have been diagnosed with ALS,” the actor revealed.
But the man, who lost the ability to talk due to amyotrophic lateral sclerosis, still says it makes him “happy” and that it feels like his real voice, according to Wairagkar.
Prescribed use of anti-anxiety drugs, hypnotics and sedatives, or antidepressants was tied to a higher future risk of amyotrophic lateral sclerosis (ALS) diagnosis and a poorer prognosis, a case ...
Corcept Therapeutics Therapy Fails Primary Goal But Extends Patient Survival In Amyotrophic Lateral Sclerosis Study by Vandana Singh Benzinga Editor Follow ...
Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting ...